Guardion Health Sciences
San Diego
About Guardion Health Sciences
Guardion is an ocular health sciences company that develops, formulates and distributes conditionspecific medical foods supported by evidence-based protocols, with an initial medical food product that addresses a depleted macular protective pigment, a known risk factor for age-related macular degeneration (“AMD”), and a significant component of functional vision performance. Guardion Health Sciences, Inc. has also developed a proprietary medical device, the MapcatSF®, which accurately measures the macular pigment density, therefore providing the only two-pronged evidence-based protocol for the treatment of a depleted macular protective pigment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $9.8M
- Funding stage: IPO
- Last round: Series Unknown (Nov 2017)
- Ticker: nasdaq:GHSI
- Website: guardionhealth.com
- Phone: +1 800-873-5141
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/guardion-health-sciences-2239903 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.